• After clinical exclusion of bacterial, viral, or fungal infections, short-term treatment of steroid responsive inflammatory diseases of the eye.
• Inflammation of the ear or nose that is not infectious.

Otitis

Eye inflammation

Nasal Problem

As eye drops:

• As 0.1% drop: Depending on the severity of the underlying problem and the response to treatment, the frequency of instillation of drops and the duration of treatment will vary. In order to achieve a decent response, one to two drops must be injected into the eye every thirty to sixty minutes. If there is no response, subconjunctival or systemic steroid therapy should be attempted. Reduce the dosage to one drop every four hours once a positive reaction has been noted.
• As 0.05% ointment: Up to four times each day, apply a 0.5-1 inch ribbon of ointment to the conjunctival sac(s). Once the condition has improved, reduce the dosage to once daily.

As ear drops:

• At a two- or three-hour interval, apply two or three drops to the ear. The frequency of dosage and treatment length may differ depending on the type of lesion and severity.

• Nasal
• • Adult: For non-infected cases of the nose: As 0.1% betamethasone Na phosphate drops: Apply 2-3 drops into each nostril twice or thrice a day as required. Use the lowest effective dose for the shortest possible time. Discontinue if there is no clinical response within 7 days of treatment.
• Ophthalmic
  
  • Adult: For short-term treatment of steroid-responsive cases: As 0.1% betamethasone Na phosphate drops: Initially, apply 1-2 drops into the affected eye(s) every 1-2 hours, then reduce frequency once the condition is under control. As 0.1% betamethasone Na phosphate ointment: Apply 2-4 times daily; alternatively, doses may be applied at night. Use the lowest effective dose for the shortest possible time. Discontinue if there is no clinical response within 7 days of treatment.

Eye Drops	Eye Drops
Ear Drops	Ear Drop

Dexamethasone sodium phosphate can cause the following side effects-

• irritation
• burning
• stinging
• itching
• dermatitis
• corneal ulceration
• posterior subcapsular cataracts (prolonged use)
• keratitis

Eye Irritation

Dermatitis

Itching

Ocular burning/ Eye burning

• Undiagnosed red eyes should never be treated with topical corticosteroids.
• Ophthalmic treatment with corticosteroid preparations should not be repeated or continued without regular monitoring to rule out increased intraocular pressure, cataract formation, or infection.